The serum concentrations of CRP, CEA, CA19-9, and GSDM D according to the sex of the tested patients (a total of patients with bladder cancer and healthy individuals) were also evaluated (Table 4). The gene discussed is GSDMA; the disease is urinary bladder carcinoma.